Activation of IND by the FDA
March 1, 2024 - Thirona is pleased to announce [...]
MannKind extends collaboration with Thirona Bio, Inc. on fibrotic lung diseases
• MannKind purchased an additional convertible note issued by Thirona [...]
EnZen Therapeutics and Thirona Bio, Inc. Announce Investment Arrangement
SAN DIEGO, Aug. 30, 2021 /PRNewswire/ -- EnZen Therapeutics, Inc. [...]
MannKind and Thirona Bio, Inc. join forces to evaluate potential inhaled therapy for fibrotic lung diseases
MannKind will conduct formulation and preclinical studies of a [...]